Ting‐Lin Yen

1.2k total citations
49 papers, 939 citations indexed

About

Ting‐Lin Yen is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Ting‐Lin Yen has authored 49 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Complementary and alternative medicine. Recurrent topics in Ting‐Lin Yen's work include Traditional Chinese Medicine Analysis (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Platelet Disorders and Treatments (5 papers). Ting‐Lin Yen is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Platelet Disorders and Treatments (5 papers). Ting‐Lin Yen collaborates with scholars based in Taiwan, India and United States. Ting‐Lin Yen's co-authors include Joen‐Rong Sheu, Thanasekaran Jayakumar, Wan‐Jung Lu, Jing‐Shiun Jan, Chih‐Hao Yang, Rajeev Taliyan, Chih-Hao Yang, Mantosh Kumar Satapathy, Jia‐Yi Wang and George Hsiao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Ting‐Lin Yen

47 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ting‐Lin Yen Taiwan 17 389 188 129 121 120 49 939
Haibo Cheng China 21 506 1.3× 174 0.9× 151 1.2× 77 0.6× 123 1.0× 79 1.1k
Liang Feng China 17 532 1.4× 158 0.8× 133 1.0× 69 0.6× 136 1.1× 42 1.1k
Liang Feng China 18 635 1.6× 158 0.8× 159 1.2× 57 0.5× 126 1.1× 89 1.3k
Jing Ren China 18 511 1.3× 106 0.6× 105 0.8× 42 0.3× 167 1.4× 60 1.4k
Jingwei Tian China 22 497 1.3× 106 0.6× 102 0.8× 49 0.4× 90 0.8× 52 1.1k
Lipeng Xu China 22 503 1.3× 274 1.5× 135 1.0× 65 0.5× 100 0.8× 57 1.3k
Zheyu Zhang China 20 545 1.4× 81 0.4× 113 0.9× 110 0.9× 112 0.9× 41 1.0k
Xing Yuan China 19 668 1.7× 131 0.7× 89 0.7× 87 0.7× 105 0.9× 43 1.0k
Marialuisa Piccolo Italy 19 385 1.0× 94 0.5× 57 0.4× 80 0.7× 65 0.5× 42 973

Countries citing papers authored by Ting‐Lin Yen

Since Specialization
Citations

This map shows the geographic impact of Ting‐Lin Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Lin Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Lin Yen more than expected).

Fields of papers citing papers by Ting‐Lin Yen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Lin Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Lin Yen. The network helps show where Ting‐Lin Yen may publish in the future.

Co-authorship network of co-authors of Ting‐Lin Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Lin Yen. A scholar is included among the top collaborators of Ting‐Lin Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Lin Yen. Ting‐Lin Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jan, Jing‐Shiun, et al.. (2025). Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches. CNS Neuroscience & Therapeutics. 31(3). e70348–e70348. 1 indexed citations
2.
Jan, Jing‐Shiun, et al.. (2025). Targeting Spermine Oxidase to Mitigate Traumatic Brain Injury Pathology in the Aging Brain. Antioxidants. 14(6). 709–709.
3.
Hsieh, Cheng-Ta, Ting‐Lin Yen, Jing‐Shiun Jan, et al.. (2025). Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications. Molecular Neurodegeneration. 20(1). 7–7. 10 indexed citations
4.
Hsia, Chih‐Wei, et al.. (2024). Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models. International Journal of Molecular Sciences. 25(4). 2098–2098. 8 indexed citations
5.
Ho, Chih‐Ming, Ting‐Lin Yen, Tzu‐Hao Chang, & Shih‐Hung Huang. (2024). COL6A3 Exosomes Promote Tumor Dissemination and Metastasis in Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 25(15). 8121–8121. 3 indexed citations
6.
Yen, Ting‐Lin, et al.. (2024). Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders. Pharmacological Research. 211. 107564–107564. 7 indexed citations
7.
Jan, Jing‐Shiun, Ting‐Lin Yen, Jia‐Yi Wang, et al.. (2024). Targeting Circadian Protein Rev-erbα to Alleviate Inflammation, Oxidative Stress, and Enhance Functional Recovery Following Brain Trauma. Antioxidants. 13(8). 901–901. 1 indexed citations
8.
Hsia, Chih‐Wei, et al.. (2023). Garcinol acts as a novel integrin αIIbβ3 inhibitor in human platelets. Life Sciences. 326. 121791–121791. 4 indexed citations
9.
10.
Jayakumar, Thanasekaran, Joen‐Rong Sheu, Kuo‐Ching Yuan, et al.. (2023). Anti-inflammatory Mechanism of Morin Hydrate by Suppressing the NF-κB/MAPKs Mediated Cell Migration and Modulating Src/FAK and β-Catenin. Natural Product Communications. 18(9). 1 indexed citations
11.
Jayakumar, Thanasekaran, et al.. (2023). Mechanisms of glabridin inhibition of integrin αIIbβ3 inside-out signals and NF-κB activation in human platelets. Chinese Medicine. 18(1). 71–71. 1 indexed citations
12.
Yen, Ting‐Lin, et al.. (2022). Advances in Antibody-Based Therapeutics for Cerebral Ischemia. Pharmaceutics. 15(1). 145–145. 7 indexed citations
13.
Jayakumar, Thanasekaran, Chun‐Jen Huang, Ting‐Lin Yen, et al.. (2022). Activation of Nrf2 by Esculetin Mitigates Inflammatory Responses through Suppression of NF-κB Signaling Cascade in RAW 264.7 Cells. Molecules. 27(16). 5143–5143. 26 indexed citations
15.
Yen, Ting‐Lin, Chao-Chien Chang, Chi‐Li Chung, et al.. (2018). Neuroprotective Effects of Platonin, a Therapeutic Immunomodulating Medicine, on Traumatic Brain Injury in Mice after Controlled Cortical Impact. International Journal of Molecular Sciences. 19(4). 1100–1100. 16 indexed citations
16.
Chang, Chao-Chien, Wan‐Jung Lu, Ting‐Lin Yen, et al.. (2017). Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies. Scientific Reports. 7(1). 40002–40002. 25 indexed citations
17.
Jayakumar, Thanasekaran, Chih-Hao Yang, Pitchairaj Geraldine, Ting‐Lin Yen, & Joen‐Rong Sheu. (2016). The pharmacodynamics of antiplatelet compounds in thrombosis treatment. Expert Opinion on Drug Metabolism & Toxicology. 12(6). 615–632. 13 indexed citations
18.
Chung, Chi‐Li, Wan‐Jung Lu, Ting‐Lin Yen, et al.. (2015). Hinokitiol Negatively Regulates Immune Responses through Cell Cycle Arrest in Concanavalin A-Activated Lymphocytes. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 4 indexed citations
20.
Lien, Li-Ming, Zhih‐Cherng Chen, Chi‐Li Chung, et al.. (2014). Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo. European Journal of Pharmacology. 737. 159–167. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026